MTAP and glioblastoma: In this study, we exploited the susceptibility of MTAP-deficient GBM cells to de novo purine synthesis inhibition and examined the effects of purine blockade on the maintenance of GBMs’ stemness, mitochondrial function, and response to chemotherapy.